Curing amyloidosis: Will it work in humans?

Trends in Neurosciences

Volumn 22, Issue 11, 1999, Pages 485-486

  Duff, Karen ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; AUTOIMMUNE DISEASE; GENE MUTATION; INFLAMMATION; MOUSE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; TRANSGENIC MOUSE;

EID: 0033231785     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(99)01489-7     Document Type: Short Survey

References (10)

1. Hardy J. Trends Neurosci. 20:1997;154-159.
2. Cruts M., Van Broeckhoven C. Ann. Med. 30:1998;560-565.
3. Games D.et al. Nature. 373:1995;523-527.
4. Schenk D.et al. Nature. 400:1999;173-177.
5. Ballow M., Nelson R. J. Am. Med. Assoc. 278:1997;2008-2017.
6. Zlokovic B.V.et al. Biochem. Biophys. Res. Commun. 197:1993;1034-1040.
7. Poduslo J.F.et al. Neurobiol. Dis. 6:1999;190-199.
8. Solomon B.et al. Proc. Natl. Acad. Sci. U. S. A. 93:1996;452-455.
9. Solomon B.et al. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4109-4112.
10. Snowdon D.A. Gerontologist. 37:1997;150-156.